Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Bone mineral density screening should be routine in lymphoma patients.

Thompson MA, Westin JR, Hagemeister FB.

Ann Oncol. 2014 Apr;25(4):913-4. doi: 10.1093/annonc/mdu044. No abstract available.

2.

Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot study.

Paccou J, Merlusca L, Henry-Desailly I, Parcelier A, Gruson B, Royer B, Charbonnier A, Ursu D, Desailloud R, Garidi R, Kamel S, Sevestre H, Marolleau JP, Fardellone P, Damaj G.

Ann Oncol. 2014 Feb;25(2):481-6. doi: 10.1093/annonc/mdt560. Epub 2014 Jan 8.

3.

Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial.

Westin JR, Thompson MA, Cataldo VD, Fayad LE, Fowler N, Fanale MA, Neelapu S, Samaniego F, Romaguera J, Shah J, McLaughlin P, Pro B, Kwak LW, Sanjorjo P, Murphy WA, Jimenez C, Toth B, Dong W, Hagemeister FB.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):99-105. doi: 10.1016/j.clml.2012.11.002. Epub 2012 Dec 29.

5.

Further studies on the treatment of Burkitt's lymphoma.

Clifford P.

East Afr Med J. 1966 Jun;43(6):179-99. No abstract available.

PMID:
5943487
6.

Chemotherapy of the non-Hodgkin's lymphomas.

Canellos GP, Lister TA, Skarin AT.

Cancer. 1978 Aug;42(2 Suppl):932-40. Review. No abstract available.

7.

Effect of prior radiotherapy on tolerance and response to chemotherapy in non-Hodgkin's lymphoma.

Bender RA, Johnson BL, Norton L, Young RC.

Am J Hematol. 1977;2(2):113-22. No abstract available.

PMID:
888822
8.

[Fourteen cases of primary malignant lymphoma of bone].

Zhou JC, Zhang GS.

Hunan Yi Ke Da Xue Xue Bao. 2003 Dec;28(6):659-60. Chinese. No abstract available.

PMID:
15804088
9.

Rituximab for treatment of chemoimmunotherapy naive marginal zone lymphoma.

Lossos IS, Morgensztern D, Blaya M, Alencar A, Pereira D, Rosenblatt J.

Leuk Lymphoma. 2007 Aug;48(8):1630-2. No abstract available.

PMID:
17701596
10.

[Possibilities and limits of chemotherapy in the treatment of malignant lymphoma].

Gross R.

Strahlentherapie Sonderb. 1969;69:75-94. German. No abstract available.

PMID:
5778911
11.
12.

Treatment of lymphomas with antineoplastic agents.

Brunk SF.

J Iowa Med Soc. 1968 Oct;58(10):1038-41. No abstract available.

PMID:
4884154
14.

Phase II trial of aziridinylbenzoquinone (AZQ) in patients with refractory lymphoma.

McLaughlin P, Cabanillas F, Bedikian AY, Bodey GP.

Cancer Treat Rep. 1983 May;67(5):507-8. No abstract available.

PMID:
6850666
15.

[Treatment of advanced non-Hodgkin's lymphoma using adriblastin and endoxan as well as ixoten].

Liffers R.

Med Welt. 1980 Jul 4;31(27):1029-32. German. No abstract available.

PMID:
7421538
16.

[Cyclic polychemotherapy of nonHodgkin's lymphoma].

Danieli G, Leoni P, Totti S, Corvetta A, Gabrielli A.

G Clin Med. 1977 Jan-Feb;58(1-2):31-41. Italian. No abstract available.

PMID:
902942
17.

[Intensive anticancer chemotherapy. Transfusion of autologous bone marrow. Rooms exempt of pathogenic germs].

Mathé G, Schwarzenberg L, Schneider M, Amiel JL, Cattan A, Schlumberger JR, Flaisler A.

Presse Med. 1966 Nov 26;74(51):2615-7. French. No abstract available.

PMID:
5332938
19.

Some problems in the management of leukaemia and lymphoma.

Galton DA.

Proc R Soc Med. 1966 Dec;59(12):1268-72. No abstract available.

20.

[Chemotherapy of malignant lymphoma].

Ota K, Oyama A.

Rinsho Hoshasen. 1973 Nov;18(11):918-29. Japanese. No abstract available.

PMID:
4797429
Items per page

Supplemental Content

Write to the Help Desk